NCT00736931View on ClinicalTrials.gov

Clinical Study in Healthy Volunteers to Investigate the Neurocognitive Effects of a New Antiepileptic Drug: Brivaracetam

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Epilepsy
Interventions
DRUG

Brivaracetam

Brivaracetam 10 mg tablets

DRUG

levetiracetam

500mg tablets

DRUG

lorazepam

lorazepam 2 mg over encapsulated tablets

OTHER

placebo

placebo capsules

Trial Locations (1)

Unknown

Overland Park

Sponsors

Lead Sponsor

UCB Pharma
All Listed Sponsors
lead

UCB Pharma

INDUSTRY

NCT00736931 - Clinical Study in Healthy Volunteers to Investigate the Neurocognitive Effects of a New Antiepileptic Drug: Brivaracetam | Biotech Hunter | Biotech Hunter